osteogenex.com osteogenex.com

osteogenex.com

Home | Osteogenex Inc. | Kansas City, KS, 66103

OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics.

http://www.osteogenex.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR OSTEOGENEX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 7 reviews
5 star
3
4 star
3
3 star
0
2 star
0
1 star
1

Hey there! Start your review of osteogenex.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.7 seconds

FAVICON PREVIEW

  • osteogenex.com

    16x16

CONTACTS AT OSTEOGENEX.COM

DOMAIN PRIVACY SERVICE FBO REGISTRANT

10 CORPOR●●●●●●●●●SUITE 300

BUR●●●TON , MASSACHUSETTS, 01803

UNITED STATES

1.87●●●●4399
WH●●●@IPAGE.COM

View this contact

DOMAIN PRIVACY SERVICE FBO REGISTRANT

10 CORPOR●●●●●●●●●SUITE 300

BUR●●●TON , MASSACHUSETTS, 01803

UNITED STATES

1.87●●●●4399
WH●●●@IPAGE.COM

View this contact

DOMAIN PRIVACY SERVICE FBO REGISTRANT

10 CORPOR●●●●●●●●●SUITE 300

BUR●●●TON , MASSACHUSETTS, 01803

UNITED STATES

1.87●●●●4399
WH●●●@IPAGE.COM

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2006 January 10
UPDATED
2013 December 16
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 18

    YEARS

  • 4

    MONTHS

  • 12

    DAYS

NAME SERVERS

1
ns1.ipage.com
2
ns2.ipage.com

REGISTRAR

FASTDOMAIN, INC.

FASTDOMAIN, INC.

WHOIS : whois.fastdomain.com

REFERRED : http://www.fastdomain.com

CONTENT

SCORE

6.2

PAGE TITLE
Home | Osteogenex Inc. | Kansas City, KS, 66103 | osteogenex.com Reviews
<META>
DESCRIPTION
OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics.
<META>
KEYWORDS
1 about ogx
2 mission and values
3 leadership team
4 management
5 board of directors
6 scientific advisory board
7 careers
8 technology
9 target history
10 bone building
CONTENT
Page content here
KEYWORDS ON
PAGE
about ogx,mission and values,leadership team,management,board of directors,scientific advisory board,careers,technology,target history,bone building,therapeutic markets,corporate,business development/partnership,investor relations,fact sheet,news,view
SERVER
openresty
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Home | Osteogenex Inc. | Kansas City, KS, 66103 | osteogenex.com Reviews

https://osteogenex.com

OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics.

INTERNAL PAGES

osteogenex.com osteogenex.com
1

Target History | Osteogenex Inc. | Kansas City, KS, 66103

http://www.osteogenex.com/target-history

Privately held company. Since its inception in late 2006, it has been capitalized using convertible notes and non-dilutive grants. OGX was founded to take advantage of new opportunities to develop safer, more effective bone building therapies. Sign up to keep updated on OGX News. Click Here to Sign up. OGX takes Pride in finding the perfect match for our team. We have created a culture that resonates our innovation.

2

Fact Sheet | Osteogenex Inc. | Kansas City, KS, 66103

http://www.osteogenex.com/fact-sheet

Download this Fact Sheet as a PDF:. Privately held company. Since its inception in late 2006, it has been capitalized using convertible notes and non-dilutive grants. OGX was founded to take advantage of new opportunities to develop safer, more effective bone building therapies. Sign up to keep updated on OGX News. Click Here to Sign up. OGX takes Pride in finding the perfect match for our team. We have created a culture that resonates our innovation.

3

Careers | Osteogenex Inc. | Kansas City, KS, 66103

http://www.osteogenex.com/careers

OGX takes Pride in finding the perfect match for our team. We have created a culture that resonates our innovation. We are looking to expand our team, do you demonstrate the talent we are seeking? Upload CV or resume. Enter Word Verification in box below *. Privately held company. Since its inception in late 2006, it has been capitalized using convertible notes and non-dilutive grants. OGX was founded to take advantage of new opportunities to develop safer, more effective bone building therapies.

4

Scientific Advisory Board | Osteogenex Inc. | Kansas City, KS, 66103

http://www.osteogenex.com/scientific-advisory-board

Debra L. Ellies Ph.D., CEO:. Harold Rosen, M.D. James Macdonald, Ph.D. Nancy Lane, M.D. Robert Young, Ph.D. Privately held company. Since its inception in late 2006, it has been capitalized using convertible notes and non-dilutive grants. OGX was founded to take advantage of new opportunities to develop safer, more effective bone building therapies. Sign up to keep updated on OGX News. Click Here to Sign up.

5

Board of Directors | Osteogenex Inc. | Kansas City, KS, 66103

http://www.osteogenex.com/board-of-directors

Debra L. Ellies Ph.D., Director and Chairwoman of Board:. William S. Rosenberg M.D., Director:. Frank Loeffler, Director:. Kelly Drouillard, Director:. Privately held company. Since its inception in late 2006, it has been capitalized using convertible notes and non-dilutive grants. OGX was founded to take advantage of new opportunities to develop safer, more effective bone building therapies. Sign up to keep updated on OGX News. Click Here to Sign up.

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

ossifi.com ossifi.com

News

http://www.ossifi.com/News.html

OsteoGeneX to Spin Off Commercialization Entity. New Chief Commercial Officer to Drive Bone Therapeutics to Market. Kansas City, KS, October 4, 2011) – OsteoGeneX, a Kansas City, Kansas- ‐based biotechnology company focusing on bone- ‐related therapeutics, announced today it will spin off a new company called OssiFi to commercialize bone graft substitutes to stimulate fracture repair, reduce the clinical rate of delayed or non- ‐unions, and accelerate return to function. OssiFi is focused on developing t...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

3

OTHER SITES

osteogenesisimperfecta.asia osteogenesisimperfecta.asia

Home

It's easy to get started creating your website. Knowing some of the basics will help. What is a Content Management System? A content management system is software that allows you to create and manage webpages easily by separating the creation of your content from the mechanics required to present it on the web. In this site, the content is stored in a. The look and feel are created by a. Brings together the template and your content to create web pages. Template, site settings, and modules. The boxes aro...

osteogenesisimperfecta.com osteogenesisimperfecta.com

The Osteogenesis Imperfecta Clinic at Kennedy Krieger Institute

The Osteogenesis Imperfecta Clinic. The Osteogenesis Imperfecta (OI) Clinic at Kennedy Krieger Institute. The Kennedy Krieger Institute OI Clinic interacts with the OI Foundation. And actively works with other OI centers and physicians around the country. The goals of the OI Clinic are to attain the best care for each individual with OI, and to investigate solutions to improve the quality of life for all people with OI. July 31, 2015. Termination of the OI Registry. February 7, 2015. November 22-23, 2014.

osteogenesisimperfecta.org osteogenesisimperfecta.org

The Osteogenesis Imperfecta Clinic at Kennedy Krieger Institute

The Osteogenesis Imperfecta Clinic. The Osteogenesis Imperfecta (OI) Clinic at Kennedy Krieger Institute. The Kennedy Krieger Institute OI Clinic interacts with the OI Foundation. And actively works with other OI centers and physicians around the country. The goals of the OI Clinic are to attain the best care for each individual with OI, and to investigate solutions to improve the quality of life for all people with OI. July 31, 2015. Termination of the OI Registry. February 7, 2015. November 22-23, 2014.

osteogenesisimperfecta101.weebly.com osteogenesisimperfecta101.weebly.com

Osteogenesis Imperfecta - Home

What is Osteogenesis Imperfecta? The Osteogenesis Imperfecta (OI) refers to an illness of genetic bone disorder. People who suffer from OI are born with defective connective tissue, or without the ability to make it. Interesting facts about Osteogenesis Imperfecta! A person with a form of OI caused by mutation has a 50% chance of passing the disorder to his or her children. Teeth brittleness is a symptom of OI, so Dental problems can happen. An Egyptian mummy from 1000 BC had OI. Create a free website.

osteogenetics.com osteogenetics.com

osteogenetics.com

osteogenex.com osteogenex.com

Home | Osteogenex Inc. | Kansas City, KS, 66103

OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. OsteoGeneX’s proprietary development approach lends itself to a safe therapeutic - with less human adverse effects in clinical trials. OstéoQC Closes Seed Financing Round. OGX was founded to take advantage of new opportunities ...

osteogenex.livepagecafe.com osteogenex.livepagecafe.com

Home | Osteogenex Inc. | Kansas City, KS, 66103

OsteoGeneX is developing a first in class bone building small molecule against the validated target Sclerostin. OsteoGeneX possesses both near term accelerated clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. OsteoGeneX’s proprietary development approach lends itself to a safe therapeutic - with less human adverse effects in clinical trials. OstéoQC Closes Seed Financing Round. OGX was founded to take advantage of new opportunities ...

osteogenez.ixbb.ru osteogenez.ixbb.ru

Хрупкие дети

160; Хрупкие дети. ЕСЛИ ВАМ НУЖНА ПОМОЩЬ. Помощь в сборе средств на лечение. 2017-04-02 13:33:47 - solenette. Как принимать кофеин бензоат натрия. 2017-04-03 15:10:15 - solenette. Форум про наших хрустальных деток. Ждем ваших рассказов о жизни своих детей и полезных советов. И если у Вас есть вопросы, спрашивайте - ответим. Макароны это сложные или простые углеводы. 2017-04-03 10:33:42 - solenette. ВСЕ О ЛЕЧЕНИИ Н.О. Информация о лечении несовершенного остеогенеза. Вопросы и ответы. Новости.

osteogenez.ru osteogenez.ru

Главная - Общественная организация "Хрупкие дети"

ЧТО ТАКОЕ НЕСОВЕРШЕННЫЙ ОСТЕОГЕНЕЗ? Несовершенный остеогенез (Osteogenesis Imperfecta) это группа генетически обусловленных заболеваний, в основе которых лежит нарушение формирования костной ткани. На практике это означает, что ребёнок с самого рождения подвержен частым переломам костей, которые происходят при минимальных воздействиях и даже в отсутствие травм. Хотя ключевые моменты патологическая ломкость костей, нарушение роста, мышечная слабость, характерные психологические особенности и позво...Выста...

osteogeneza.pl osteogeneza.pl

osteogeneza.pl - This website is for sale! - osteogeneza Resources and Information.

The owner of osteogeneza.pl. Is offering it for sale for an asking price of 2000 EUR! The domain osteogeneza.pl. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

osteogenics.com osteogenics.com

Osteogenics Biomedical, Home Page

Cytoplast RTM Absorbable Dental Wound Dressings. Master Pin Control Fixation System. Pro-fix Precision Fixation System. Ridge Preservation Kit: Cytoplast Technique. SinCrest Sinus Lift Kit. Registration Now Available for the Osteogenics 2018 Global Bone Grafting Symposium. For more information or to register for the symposium. Zmatrix , Osteogenics Newest Collagen Membrane. For more information or to purchase Zmatrix membranes online. Join Our Email List.